The antinociceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors

Anesthesia and Analgesia

Volumn 104, Issue 6, 2007, Pages 1563-1569

  Guindon, Josée ^a   LoVerme, Jesse ^b   Piomelli, Daniele ^b   Beaulieu, Pierre ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; AMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; FATTY ACID; FORMALDEHYDE; INTRALIPID; PALMIDROL; PROPOFOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HINDLIMB; INJECTION; MALE; MASS SPECTROMETRY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANALGESICS; ANIMALS; ENDOCANNABINOIDS; INJECTIONS, SUBCUTANEOUS; MALE; PAIN MEASUREMENT; PROPOFOL; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 34249023290     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000263278.05423.a3     Document Type: Article

References (36)

1. Smith I, White PF, Nathanson M, et al. Propofol: an update on its clinical use. Anesthesiology 1994;81:1005-43.
2. Sun YY, Li KC, Chen J. Inhibitory effects of spinal propofol on the responses of spinal dorsal horn neurons in normal rats. Sheng Li Xue Bao 2004;56:444-50.
3. Nadeson R, Goodchild CS. Antinociceptive properties of propofol: involvement of spinal cord gamma-aminobutyric acid(A) receptors. J Pharmacol Exp Ther 1997;282:1181-6.
4. Anwar MM, Abdel-Rahman MS. Effect of propofol on perception of pain in mice: mechanisms of action. Comp Biochem Physiol A Mol Integr Physiol 1998;120:249-53.
5. Antognini JF, Wang XW, Piercy M, Carstens E. Propofol directly depresses lumbar dorsal horn neuronal responses to noxious stimulation in goats. Can J Anaesth 2000;47:273-9.
6. Sun YY, Li KC, Chen J. Evidence for peripherally antinociceptive action of propofol in rats: behavioral and spinal neuronal responses to subcutaneous bee venom. Brain Res 2005;1043:231-5.
7. Patel S, Wohlfeil ER, Rademacher DJ, et al. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol 2003;139:1005-13.
8. Rice AS, Farquhar-Smith WP, Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 2002;66:243-56.
9. Walczak JS, Pichette V, Leblond F, et al. Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 2005;132:1093-102.
10. Galiègue S, Mary S, Marchand J, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995;232:54-61.
11. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 2000;21:218-24.
12. Fowler CJ, Stenstrom A, Tiger G. Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. Pharmacol Toxicol 1997;80:103-7.
13. Fowler CJ. Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. Trends Pharmacol Sci 2004;25:59-61.
14. Guindon J, De Léan A, Beaulieu P. Local interactions between anandamide, an endocannabinoid, and ibuprofen, an NSAID, in acute and inflammatory pain. Pain 2006;121:85-93.
15. Guindon J, Beaulieu P. Analgesic effects of anandamide, non steroidal anti-inflammatory drugs and their combination in a rat model of neuropathic pain. Neuropharmacology 2006;50:814-23.
16. Gatley SJ, Gifford AN, Volkow ND, et al. 123I-labelled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 1996;307:331-8.
17. Pertwee RG, Griffin G, Fernando S, et al. AM630, a competitive cannabinoid receptor antagonist. Life Sci 1995;56:1949-55.
18. Tjölsen A, Berge OG, Hunskaar S, et al. The formalin test: an evaluation of the method. Pain 1992;51:5-17.
19. Watson GS, Sufka KJ, Coderre TJ. Optimal scoring strategies and weights for the formalin test in rats. Pain 1997;70:53-8.
20. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001;93:239-45.
21. Giuffrida A, Rodriguez de Fonseca F, Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 2000;280:87-93.
22. Nackley AG, Suplita RL II, Hohmann AG. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 2003;117:659-70.
23. DeLéan A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-E102.
24. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971.
25. Draper NR, Smith H. Applied regression analysis. New York: Wiley, 1998.
26. Evans MS, Reid KH, Sharp JB Jr. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia. Neurosci Lett 1993;150:145-8.
27. Theophilidis G, Kravari K. Dimethylsulfoxide (DMSO) eliminates the response of the sensory neurones of an insect mechanoreceptor, the femoral chordotonal organ of Locusta migratoria, but blocks conduction of their sensory axons at much higher concentrations: a possible mechanism of analgesia. Neurosci Lett 1994;181:91-4.
28. Kathuria S, Gaetani S, Fegley D, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003;9:76-81.
29. Mazzari S, Canella R, Petrelli L, et al. N-(2-Hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996;300:227-36.
30. Calignano A, La Rana G, Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 2001;419:191-8.
31. Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996;278:989-99.
32. Lambert DM, DiPaolo FG, Sonveaux P, et al. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta 1999;1440:266-74.
33. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998;394:277-81.
34. Beaulieu P, Bisogno T, Punwar S, et al. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol 2000;396:85-92.
35. Cravatt BF, Demarest K, Patricelli MP, et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 2001;98:9371-6.
36. Shibakawa YS, Sasaki Y, Goshima Y, et al. Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth 2005;95:803-10.